View in browser

Moores Cancer Center, as part of Curebound, has received significant funding from the Cure Prizes initiative.The Cure Prizes initiative has funded 20 grants totaling $8.5 million in funding. Notably, 17 of these grants are led by Principal Investigators (PIs) from Moores Cancer Center (MCC), University of California San Diego (UCSD), and Rady Children’s Hospital, San Diego (RCHSD). This concentration of grants highlights the substantial contributions and leadership of our institution in advancing innovative cancer research and care.

Dr. Mojgan Hosseini has assumed the position of Medical Director for Pathology at Moores Cancer Center. In her new role, Dr. Hosseini will strengthen the collaboration between Moores Cancer Center and the Department of Pathology. Her responsibilities include coordinating and promoting collaboration between UCSD Cancer Services and Pathology, specifically with our disease teams to enhance multidisciplinary care. Moreover, she will act as a translational research director for cancer pathology, fostering collaborative efforts and leadership among basic and translational teams at MCC, including Research Programs and disease-focused translational teams.

February 13, 2024 | 12:00 p.m.

Comer Commons

February 13, 2024 | 12:00 p.m.

Leichtag Biomedical Research Building Room 107

February 14, 2024 | 12:00 to 1:00 p.m.

Leichtag Biomedical Research Building Room 107

February 20, 2024 | 12:00 p.m.

Leichtag Biomedical Research Building Room 107

Join Drs. Pamela Maher, Claude Sirlin and Carrie House to gain expert advice from UC San Diego, San Diego State University, and Salk Institute for Biological Studies faculty members. All students, postdocs, and junior faculty are welcome to attend!

Dr. Jing Yang and Dr. Dan Donoghue are opening the call for nominations for the NCI T32 Training Grant in Cancer Cell Signaling & Communication Program. They are looking for outstanding postdoctoral trainees working on cancer research projects from your lab. All trainees accepted into their program are expected to have strong and diverse backgrounds in cancer biology, biochemistry, molecular and cell biology, chemistry, or bioengineering. Nominations for the training program must be submitted by February 19, 2024.

As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications must be submitted by March 1, 2024.

Summer research fellowships are available in Metabolic Disease for deserving and committed UCSD undergraduates focused on obesity, diabetes, and related disorders. Ten week stipends will be available for selected candidates to work in laboratories at UCSD or the Salk Institute led by principal investigators who are members in good standing of the UCSD Diabetes Research Center. Applications are due on March 1, 2024, and should be emailed to saltieladmin@health.ucsd.edu  

The CT2 Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at the Moores Cancer Center. Trainees not only execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center, but also participate in coursework, seminars, and lectures. Graduates of the program are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment.

Applications must be submitted by March 15, 2024.

Winn CDA is a 2-year program designed to support the career development of early-stage investigator physicians who are underrepresented in medicine (URiM) or who have a demonstrated commitment to increasing diversity in clinical research. The program prepares participants to become independent clinical trial investigators engaged in advancing health equity through their research and mentoring. The goal of Winn CDA is to transform the clinical research landscape by building and strengthening partnerships between clinical investigators and the communities where their patients reside, with a goal of ultimately engaging a patient population that mirrors the epidemiology of the disease studied.

Application Period: January 2, 2024 to May 13, 2024

This seed grant funding opportunity supports preliminary findings and exploratory new concepts in early to late- stage gene therapy-related programs. Our aim is to help bridge critical gaps between good ideas and breakthrough discoveries by fostering collaborative interactions to expedite the translation of research into therapeutic treatments. Up to $100K will be awarded per project over a one-year term. 

Deadline: Friday, March 1, 2024

Questions? Contact GTI_admin@health.ucsd.edu

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate development, innovation and establishment of adoptive cellular therapy clinical trials for treatment of pediatric patients (18 years or younger) with solid tumors. Specifically, UG3 phase of the awards will support preclinical, translational and investigational new drug (IND)-enabling studies that lay groundwork for UH3 early-stage clinical trials testing adoptive immune cell therapies in pediatric patients with solid tumors. The successful applications will add to ­the newly established Cancer Adoptive Cellular Therapy (Can-ACT) Network, dedicated to developing innovative cell therapy approaches for the treatment of solid tumors in pediatric and adult cancer patients. This Network of investigators will, through novel and collaborative approaches to preclinical and translational studies, bring new cell therapy products into clinical trials.

Deadline: March 6, 2024

The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Amount awarded is $3,000,000 disbursed over a 3-year term.

LOI Due: March 12th, 2024

Journal for ImmunoTherapy of Cancer

Gregory Botta, MD, PhD (Cancer Biology and Signaling)

Science Immunology

Daniela Weiskopf, PhD (Hematologic Malignancies), Alessandro Sette, PhD (NPA)

Nature Communications

Laura Crotty Alexander, MD (Cancer Control Program), Debashis Sahoo, PhD (Structural and Functional Genomics), Gourisankar Ghosh, PhD (Solid Tumor Therapeutics), Pradipta Ghosh, MD (Cancer Biology and Signaling)

PI: Sandip Patel, MD

NCT: NCT05736731

PI: Sandip Patel, MD

NCT: NCT05259696

The Moores Cancer Center is excited to be growing its Community Outreach & Engagement team and is looking for a coordinator to join them! As a coordinator, you'll play a crucial role in overseeing cancer prevention outreach efforts, supporting data collection and assisting internal projects efforts around cancer prevention. Please share with your network!

Apply Now

Mark your calendars for Tuesday, February 27th, from 12:00 PM to 1:30 PM, as the UC San Diego Moores Cancer Center and its partners commemorate a decade of strides in the fight against colorectal cancer during their 10th Annual Colorectal Cancer Screening Roundtable! Register today to gain insights into the latest trends, screening data, policy updates, and best practices aimed at boosting colorectal cancer screening rates and saving lives. We hope to see you there!

Register Now

You’re invited to our 4th Annual Make SD HPV Cancer Free Summit on Monday, March 4th from 10-11:30am! Join us for updates on HPV vaccination rates, HPV cancer trends, and best practices, strategies and case studies for improving HPV cancer prevention in our community. 

Make progress on writing projects in a supportive community with other faculty! This 2-day retreat is organized by the Center for Faculty Diversity and Inclusion and facilitated by Chrissy Sharp, Director of Writing and Communication Learning Services at the Commons. Enrollment in the retreat includes facilitation, meals, optional writing consults, and support for dependent care. Applications are due on February 20, 2024.

Apply Now

Join us for our first Health Justice, Equity, Diversity, and Inclusion (JEDI) Town Hall on Tuesday, February 27, from Noon to 1 p.m. We will share the department’s journey over the past two years, including our vision, mission, strategic goals, and current key initiatives.  

Zoom link: https://uchealth.zoom.us/j/89569847588

Password: healthjedi – all lowercase and no spaces

I Can’t Stop Thinking of You: Tips for Handling Missing Data from Research with Dr. Fernando Wagner, Professor and Methodologist, School of Social Work – University of Maryland

Thursday, February 22, 2024, 10am PST/ 1pm EST | Register Now

Avoid the Disappearing Act: The Importance of and Strategies to Consider for Project or Intervention Sustainability with Dr. Lourdes Baezconde-Garbanati, Professor of Preventive Medicine, Associate Dean for Community Initiative, Associate Director for Community Outreach and Engagement, Keck School of Medicine, University of Southern California

Thursday, March 21, 2024, 10am PDT/ 1pm EST | Register Now

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

Unsubscribe | Privacy Policy | Submit Feedback